News and Publications

Categories

WEBPORTAL

  • Improving our ability to diagnose Hemoglobinopathies.

    ARCHIMEDlife News October 1, 2018

    Results of a prospective study using High-Resolution Mass Spectrometry. The goal of our study, in cooperation with the University Medical Center Hamburg in Eppendorf Germany,… Read more

  • First LEA assay launched

    ARCHIMEDlife News March 14, 2018
    LEA2 MPS Panel Our first LEA2 (Lysosomal Enzyme Activity) assay has now been started and with it several mucopolysaccharidoses (MPS) can be diagnosed from one… Read more

  • Awarded work: Hemoglobinopathies and Thalassemias

    Publications , Research & Developement March 14, 2018
    Our awarded work (Poster Finalist at MSACL Europe, also see the PDF Poster Hemoglobinopathies_MSACL) on hemoglobinopathies and thalassemias is now starting into a prospective study in… Read more

  • Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine (Lyso-Gb3) and time to initiation of enzyme replacement therapy, an observational study

    Publications March 7, 2018
    Introduction: Methods: Results:  Conclusion: Authors / corresponding author*  JAlbinaNowakaSarah H.HailebDavid C.KaspercThomas P.MechtlercAndreas J.FlammeraPierre A.KrayenbuehldDaniel P.Franzena   University Hospital Zurich, Zurich, Switzerland b University Zurich, Zurich,… Read more

  • Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium

    ARCHIMEDlife News March 7, 2018
    The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients, otherwise women at risk might be… Read more

  • 5 years ARCHIMEDlife – Thanks to our partners, clients and friends!

    ARCHIMEDlife News November 21, 2017
    The 21st of November 2017  is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve a successful company with dedicated people… Read more